Companies covered: Wuxi Biologics Cayman ADR (OTCMKTS:WXXWY), Gilead Sciences, Inc. (NASDAQ:GILD), Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), AbbVie Inc. (NYSE:ABBV), Pfizer, Inc. (NYSE:PFE), Moderna (NASDAQ:MRNA), BioNTech SE (ADR) (NASDAQ:BNTX), Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), United Therapeutics Corporation (NASDAQ:UTHR), Akeso, Inc. (OTCMKTS:AKESF), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Jazz Pharmaceuticals plc (NASDAQ:JAZZ), Eli Lilly and Company (NYSE:LLY), Opthea Limited (NASDAQ:OPT), Biogen Inc. (NASDAQ:BIIB), Novo Nordisk A/S (NYSE:NVO), UCB Unsponsored Belgium ADR (OTCMKTS:UCBJY), Roche Holdings Ltd. (ADR) (OTCMKTS:RHHBY), Krystal Biotech (NASDAQ:KRYS), Omeros Corporation (NASDAQ:OMER), Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Cidara Therapeutics Inc. (NASDAQ:CDTX), Alcon AG (NYSE:ALC), RxSight Inc. (NASDAQ:RXST), STAAR Surgical Company (NASDAQ:STAA), Glaukos Corp (NYSE:GKOS), Penumbra Inc. (NYSE:PEN), Stryker Corporation (NYSE:SYK), DexCom, Inc. (NASDAQ:DXCM), Abbott Laboratories (NYSE:ABT), Merit Medical Systems, Inc. (NASDAQ:MMSI), Globus Medical, Inc. (NYSE:GMED), Medtronic, Inc. (NYSE:MDT), Johnson & Johnson (NYSE:JNJ), Zimmer Biomet Holdings Inc. (NYSE:ZBH), AngioDynamics, Inc. (NASDAQ:ANGO), Cooper Companies, Inc. (The) (NYSE:COO), Allurion Technologies Inc. (NYSE:ALUR), Alphatec Holdings, Inc. (NASDAQ:ATEC), Sensus Healthcare (NASDAQ:SRTS), Journey Medical Corp. (NASDAQ:DERM), Abivax SA (NASDAQ:ABVX), Alpha Tau Medical Ltd. (NASDAQ:DRTS), BioHarvest Sciences Inc. (NASDAQ:BHST), BiomX Inc. (NYSEAMERICAN:PHGE), BioVie Inc. (NASDAQ:BIVI), CytoMed Therapeutics Ltd. (NASDAQ:GDTC), Lifeward Ltd. (formerly ReWalk) (NASDAQ:LFWD), MAIA Biotechnology Inc. (NYSEAMERICAN:MAIA), Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), Mira Pharmaceuticals, Inc. (NASDAQ:MIRA), NeurAxis, Inc. (NYSEAMERICAN:NRXS), Puma Biotechnology Inc (NYSE:PBYI)
